Oro Lesion was developed with your workflow in mind. As a saliva-based DNA screening test, it’s easily incorporated into routine dental visits, hygiene appointments, or focused evaluations of persistent oral symptoms—no special equipment, training, or procedural changes required.
The test involves a quick oral rinse using a provided collection kit and takes just minutes to administer chairside. Samples are processed in a CLIA-certified lab, and secure digital results are delivered within days to support clinical decision-making.
Whether you're evaluating an ambiguous lesion, managing a high-risk patient, or seeking clarity before referring to a specialist, Oro Lesion fits naturally into your diagnostic toolkit.
Visual examination remains the foundation of oral cancer screening, but even the most experienced eye can miss what lies beneath. Oro Lesion is designed to complement, not substitute, your visual and tactile assessments by detecting molecular signals invisible to the naked eye.
By analyzing somatic mutations in DNA patterns shed by precancerous and cancerous lesions, Oro Lesion adds a critical layer of insight—especially in cases where a lesion appears clinically ambiguous or when patients fall into high-risk categories.
It’s not a diagnostic tool or a hereditary risk test, and it should always be used as part of a comprehensive evaluation. Combined with your clinical expertise, Oro Lesion helps triage lesions, reduce unnecessary biopsies, and ensure timely referral and follow-up care.
